NZ187894A - Pressure pack formulations of lecithin or a sorbitan or sorbitol ester - Google Patents

Pressure pack formulations of lecithin or a sorbitan or sorbitol ester

Info

Publication number
NZ187894A
NZ187894A NZ187894A NZ18789478A NZ187894A NZ 187894 A NZ187894 A NZ 187894A NZ 187894 A NZ187894 A NZ 187894A NZ 18789478 A NZ18789478 A NZ 18789478A NZ 187894 A NZ187894 A NZ 187894A
Authority
NZ
New Zealand
Prior art keywords
dispersion
suspension
propellant
sorbitan
suspension according
Prior art date
Application number
NZ187894A
Other languages
English (en)
Inventor
K Brown
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10303374&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ187894(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of NZ187894A publication Critical patent/NZ187894A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/124Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
NZ187894A 1977-07-19 1978-07-18 Pressure pack formulations of lecithin or a sorbitan or sorbitol ester NZ187894A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3016977 1977-07-19

Publications (1)

Publication Number Publication Date
NZ187894A true NZ187894A (en) 1984-05-31

Family

ID=10303374

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ187894A NZ187894A (en) 1977-07-19 1978-07-18 Pressure pack formulations of lecithin or a sorbitan or sorbitol ester

Country Status (15)

Country Link
JP (1) JPS5435209A (ja)
AU (1) AU522792B2 (ja)
BE (1) BE869055A (ja)
CA (1) CA1112567A (ja)
CH (1) CH627075A5 (ja)
DE (1) DE2831419A1 (ja)
FR (1) FR2397833A1 (ja)
HK (1) HK51585A (ja)
IE (1) IE47128B1 (ja)
IL (1) IL55161A (ja)
IT (1) IT1158890B (ja)
MY (1) MY8400252A (ja)
NL (1) NL7807625A (ja)
NZ (1) NZ187894A (ja)
SE (1) SE443087B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
HU205249B (en) * 1990-11-09 1992-04-28 Egyt Gyogyszervegyeszeti Gyar Process for producing suspensive aerosole composition
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB367276A (en) * 1931-06-20 1932-02-18 Schmidt Sche Heissdampf Improvements in or relating to independently fired steam superheaters
BE555319A (ja) * 1956-03-21 1900-01-01
BE556587A (ja) * 1957-01-31 1957-04-11
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
US3513104A (en) * 1965-03-26 1970-05-19 Colgate Palmolive Co Self-propelling powder compositions
US3560507A (en) * 1968-02-27 1971-02-02 Millmaster Onyx Corp Quaternary ammonium alkenyl succinates
ZA72434B (en) * 1971-01-25 1973-09-26 Colgate Palmolive Co Fabric conditioning
DE2151706B1 (en) * 1971-10-18 1973-05-03 Cegla, Ulrich, Dr med , 600 0 Frank fürt Niederrad Tantalum-contg x-ray contrast agents - in aerosol form for bronchography
IL44022A0 (en) * 1973-01-23 1974-05-16 Fisons Ltd Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them
IT1039699B (it) * 1975-07-03 1979-12-10 Prephar Composizione spermicida a base di derivati benzisotiazolici
IL51314A (en) * 1976-01-30 1980-03-31 Fisons Ltd Disodium cromoglycate of low moisture content and pharmaceutical compositions containing it
GB1562901A (en) * 1976-01-30 1980-03-19 Fisons Ltd Disodium cromoglycate
GB2001334B (en) 1977-07-19 1982-03-03 Fisons Ltd Pressurised aerosol formulation
GB1590126A (en) 1977-11-23 1981-05-28 Booth B H Method of bulking yarns

Also Published As

Publication number Publication date
IE781432L (en) 1979-01-19
DE2831419A1 (de) 1979-02-01
IT1158890B (it) 1987-02-25
DE2831419C2 (ja) 1989-01-05
BE869055A (fr) 1979-01-17
IL55161A0 (en) 1978-09-29
JPS6411615B2 (ja) 1989-02-27
FR2397833A1 (fr) 1979-02-16
IL55161A (en) 1981-12-31
SE443087B (sv) 1986-02-17
AU522792B2 (en) 1982-06-24
SE7807934L (sv) 1979-01-20
IT7825845A0 (it) 1978-07-18
NL7807625A (nl) 1979-01-23
HK51585A (en) 1985-07-12
JPS5435209A (en) 1979-03-15
IE47128B1 (en) 1983-12-28
FR2397833B1 (ja) 1982-06-25
MY8400252A (en) 1984-12-31
AU3805778A (en) 1980-01-17
CH627075A5 (en) 1981-12-31
CA1112567A (en) 1981-11-17

Similar Documents

Publication Publication Date Title
DE69111426T2 (de) Treibmittelzubereitungen.
US4405598A (en) Composition for treating asthma
EP1372608B1 (de) Medizinische aerosolformulierungen
DE69101639T2 (de) Anwendung von löslichen fluorhaltigen tensiden zur herstellung von aerosol-präparaten mit dosierter abgabe.
EP0209547B1 (en) Drug-containing chlorofluorocarbon aerosol propellent formulations
DE69124374T2 (de) Druckaerosolzusammensetzung
US3095355A (en) Aerosol composition
DE69112635T2 (de) Aerosole die arzneimittel enthalten.
DE69915144T2 (de) Aerosoldruckdosiergeräte und Aerosolarzneizusammensetzungen
EP0932397B2 (en) Medicinal aerosol formulations comprising budesonide
EP1102579A1 (de) Medizinische aerosolformulierungen
EP1100465A1 (de) Medizinische aerosolformulierungen
SI9110155A (sl) Novi poganjalni plini in njihova uporaba v pripravkih zdravil
US20100095963A1 (en) Pharmaceutical compositions
CZ20012217A3 (cs) Farmaceutické aerosolové přípravky obsahující fluoralkany a budesonid
KR20000035879A (ko) 클로로플루오로카본-비함유 모메타손 푸로에이트 에어로졸 제형
NZ187894A (en) Pressure pack formulations of lecithin or a sorbitan or sorbitol ester
EP1161225B1 (de) Dosieraerosole mit isobutan als treibmittel
JP2617389B2 (ja) エーロゾル組成物及びその製造方法
RU2521975C1 (ru) Комбинированный аэрозольный препарат на основе салметерола и флутиказона для лечения заболеваний органов дыхания
TW202128159A (zh) 含茚達特羅的吸入氣霧劑藥物組合物及其製備方法
DE19908210A1 (de) Stabile, FCKW-freie Arzneimittelaerosole